Workflow
MDB Capital Holdings Provides First Quarter 2025 Update
GlobeNewswire· 2025-05-21 13:00
Management to Host Conference Call Today at 4:30 p.m. ET Addison, TX, May 21, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) ("MDB"), a public venture platform focused on launching category-leading disruptive technology companies, today provides an update on operations through and subsequent to the quarter ended March 31, 2025. First Quarter 2025 and Subsequent Operational Highlights "Despite the market volatility and cautious investor climate, we are seeing a steady flow of micro-cap co ...
ibex Launches the 2025 CX Leadership Awards
GlobeNewswire· 2025-05-21 13:00
WASHINGTON, May 21, 2025 (GLOBE NEWSWIRE) -- ibex (NASDAQ: IBEX), the leading global provider of business process outsourcing (BPO) and AI-powered CX solutions, today kicked off the 2025 CX Leadership Awards, which honor the top customer experience (CX) innovators, leaders, and contributors around the world. Industry's Top Awards Celebrate the Innovators and Game-Changers in Customer Experience About ibex ibex delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisitio ...
Opus One Gold Obtains 3.79 g/t Gold Over 6.7 m at 57 m From Hole NO-25-03 on its Zone 1 Gold Discovery, Noyell Project
GlobeNewswire· 2025-05-21 13:00
NOT FOR DISTRIBUTION TO U.S NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 21, 2025 (GLOBE NEWSWIRE) -- Opus One Gold Corp (TSX-V: OOR) (the "Company" or "Opus One") is pleased to announce that drill hole NO-25-03 from the winter drilling program on its 100% owned Noyell project near the town of Matagami, Abitibi, Québec, Canada, returned 3.79 g/t Au over 6.7 m from 57.2 to 63.9 m. The mineralized interval represents a true width of approximately 5.26 m within the Zone 1 structure ...
United-Guardian Appoints New Board Member
GlobeNewswire· 2025-05-21 13:00
Contact: Donna Vigilante (631) 273-0900 dvigilante@u-g.com NOTE: This press release contains both historical and "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements about the company's expectations or beliefs concerning future events, such as financial performance, business prospects, and similar matters, are being made in reliance upon the "safe harbor" provisions of that Act. Such statements are subject to a variety of factors that coul ...
Cloudastructure Expands into Construction Market with Initial Sales of Mobile Surveillance Trailer Alpha™
GlobeNewswire· 2025-05-21 13:00
With installations often spread across rural and isolated areas, rapid response is a critical requirement. Chief Revenue Officer Lauren OBrien noted, "Construction companies demand agility, real-time responsiveness, and scalable oversight. We're proud to provide that—especially in industries where theft and vandalism can lead to costly delays and significant project overruns." The Rising Cost of Construction Theft Construction site theft is a growing national concern, with annual losses estimated between $3 ...
Extension of the powers of a Member of the Management Board of AS Merko Ehitus
GlobeNewswire· 2025-05-21 13:00
Urmas Somelar Head of Finance AS Merko Ehitus +372 650 1250 urmas.somelar@merko.ee AS Merko Ehitus (group.merko.ee) group companies construct buildings and infrastructure and develop real estate. We create a better living environment and build the future. We operate in Estonia, Latvia, and Lithuania. As at the end of 2024, the group employed 605 people, and the group's revenue for 2024 was EUR 539 million. The Supervisory Board of AS Merko Ehitus decided to extend the powers of a Member of the Management Bo ...
XBP Europe to Update Investors at the Emerging Growth Conference on May 22, 2025
GlobeNewswire· 2025-05-21 12:58
XBP Europe invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth ConferenceLONDON and SANTA MONICA, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- XBP Europe Holdings, Inc. (“XBP Europe” or “the Company”) (NASDAQ: XBP), a pan-European integrator of bills, payments, and related solutions and services seeking to enable the digital transformation of its clients, is pleased to announce that it will be giving an update ...
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
GlobeNewswire· 2025-05-21 12:55
Study is expected to deliver final device data and documentation needed for planned FDA IND submissionSARASOTA, FL, May 21, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced that it has entered into a service agreement with medical technology provider Resyca BV for a drug-device study of the formulation-specific microchip-based nasal spray system used in ...
IDEX Biometrics ASA: Annual general meeting held on 21 May 2025
GlobeNewswire· 2025-05-21 12:45
IDEX Biometrics ASA held the annual general meeting on 21 May 2025. All resolutions were passed as proposed in the notice and agenda update for the meeting. The minutes of the meeting will be available at the company's web site www.idexbiometrics.com in due course. For further information, please contact: Kristian Flaten, CFO, Tel: +47 95092322 E-mail: ir@idexbiometrics.com About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authenticatio ...
Silexion Therapeutics Completes Key Preclinical Studies Exploring SIL204’s Potential Impact on Colorectal and Lung Cancer
GlobeNewswire· 2025-05-21 12:45
Silexion’s new groundbreaking study explores the potential impact of its next generation RNAI therapeutic candidate beyond pancreatic cancer aiming to address critical unmet needs in additional KRAS-driven tumor types with treatment markets estimated at over $30 Billion Dollars a yearGRAND CAYMAN, Cayman Islands, May 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech company developing RNA interference (RNAi) therapies for KRAS-driv ...